Skip to main content

Table 6 Table showing multiplicity and axillary lymph nodes status by the different imaging modalities in neo-adjuvant group

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Multiplicity

Multiplicity

Count

%

 SM post chemotherapy

Single

7/13

53.8%

Multiple

3/13

23.1%

No

3/13

23.1%

 DCE-MRI post chemotherapy

Single

6/13

46.2%

Multiple

3/13

23.1%

No

4/13

30.8%

 Postoperative pathology

Single

3/13

23.1%

Multiple

3/13

23.1%

Lymph nodes

LN status

Count

%

 SM post chemotherapy ALN

Pathological

5/13

30.8%

Non specific

8/13

61.5%

 SM post chemotherapy other LNs

Non specific

13/13

100.0%

 DCE-MRI post chemotherapy ALN

pathological

5/13

38.4%

Non specific

8/13

61.5%

 MRI Post chemotherapy other LNs

Non specific

13/13

100.0%

 DWI-MRI post chemotherapy ALN

pathological

4/13

30.8%

Non specific

9/13

69.2%

 DWI-MRI post chemotherapy other LNs

Non specific

13/13

100.0%

 Postoperative pathology

pathological

5/13

38.4%

Non specific

8/13

61.5%